CORA CAPITAL ADVISORS LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1964530
MARLTON, NJ
Position in REGN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$221,980
-$55,397 QoQ
Shares Held
356
-0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#412
of 584 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CORA CAPITAL ADVISORS LLC holds $358,486 across 2 Biotechnology names. REGN ranks #1 (61.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
356 | $221,980 | |
| 2 | OCGN |
Ocugen, Inc.
|
89,220 | $136,506 |
All Filings in REGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $221,980 | 356 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $277,377 | 359 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $203,773 | 264 | Shares | Sole | 2026-01-28 | |
| No filing history on record for this holder in this stock. | ||||||